Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude mice

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4857-4863

  Couillard, Steeve ^a   Gutman, Matthieu ^a   Labrie, Fernand ^a   Candas, Bernard ^a   Labrie, Claude ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 METHYL 2 [4 [2 (1 PIPERIDINYL)ETHOXY]PHENYL] 7 PIVALOYLOXY 2H 1 BENZOPYRAN 3 YLPHENYL] PIVALATE; ANTIESTROGEN; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; RADIATION DOSE; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 0033214438     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer Statistics. CA Cancer J. Clin., 49: 8-31, 1999.
2. Prout, G. R., Kliman, B., Daly, J. J., MacLaughlin, R. A., Griffin, P. P., and Young, H. H. Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary-gonadal axis. Urology, 7: 148-155, 1976.
3. McGuire, W. L., Carbone, P. P., Seard, M. E., and Esche, G. C. Estrogen receptors in human breast cancer: an overview. In: W. L. McGuire, P. P. Carbone, and E. P. Vollmer (eds.), Estrogen Receptors in Human Breast Cancer, pp. 1-7. New York: Raven Press, 1975.
4. Gradishar, W. J., and Jordan, V. C. Clinical potential of new antiestrogens. J. Clin. Oncol., 15: 840-852, 1997.
5. Labrie, C., Martel, C., Dufour, J. M., Lévesque, C., Mérand, Y., and Labrie, F. Novel compounds inhibit estrogen formation and action. Cancer Res., 52: 610-615, 1992.
6. Wakeling, A. E. The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Res. Treat., 25: 1-9, 1993.
7. Gauthier, S., Caron, B., Cloutier, J., Dory, Y.L., Favre, A., Larouche, D., Mailhot, J., Ouellet, C., Schwerdtfeger, A., Leblanc, G., Martel, C., Simard, J., Mérand, Y., Bélanger, A., Labrie, C., and Labrie, F. (S)-(+)-4-[7-(2,2-Dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy] phenyl]-2H-1-benzopyran-3-yl]-phenyl]-2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active non steroidal antiestrogen. J. Med. Chem., 40: 2117-2122, 1997.
8. Luo, S., Martel, C., Gauthier, S., Mérand, Y., Bélanger, A., Labrie, C., and Labrie, F. Long term inhibitory effects of a novel antiestrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice. Int. J. Cancer, 73: 735-739, 1997.
9. Luo, S., Martel, C., Sourla, A., Gauthier, S., Mérand, Y., Bélanger, A., Labrie, C., and Labrie, F. Comparative effects of 28-day treatment with the new antiestrogen EM-800 and tamoxifen on estrogen-sensitive parameters in the intact mouse Int. J. Cancer, 73: 381-391, 1997.
10. Tremblay, A., Tremblay, G. B., Labrie, C., Labrie, F., and Giguère, V. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors α and β. Endocrinology, 139: 111-118, 1998.
11. Tremblay, G. B., Tremblay, A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A , Labrie, F., and Giguère, V. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β. Mol. Endocrinol., 11: 353-365, 1997.
12. Labrie, F., Champagne, P., Labrie, C., Bélanger, A., Roy, J., Laverdière, J., Deschênes, L., Provencher, L., Potvin, M., Drolet, Y., Pollak, M., L'Espérance, B., Dufresne, J., Latreille, J., Robert, J., Samson, B., Jolivet, J., Cusan, L., Diamond, P., and Candas, B. Response to the orally active specific antiestrogen EM-800 (SCH57050) in tamoxifen-resistant breast cancer. 20th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, 211 (Abstract), 1997.
13. Pilepich, M. V., Krall, J. M., Al-Sarraf, M., John, M. J., Doggett, R. L., Sause, W. T., Lawton, C. A., Abrams, R. A., Rotman, M., Rubin, P., Shipley, W. U., Grignon, D., Caplan, R., and Cox, J. D. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology, 45: 616-623, 1995.
14. Pederson, L. C., Buchsbaum, D. J., Vickers, S. M., Kancharla, S. R., Mayo, M. S., Curiel, D. T., and Stackouse, M. A. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res., 57: 4325-4332, 1997.
15. Clarke, M., Collins, R., Davies, C., Godwin, J., Gray, R., and Peto, R. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 351: 1451-1467, 1998.
16. Suit, H., Shalek, R., and Wette, R. Radiation response of C3H mouse mammary carcinoma evaluated in terms of cellular radiosensitivity, pp. 514-530. Baltimore: Williams & Wilkins Co., 1965.
17. 5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res., 46: 4933-4937, 1986.
18. Dauvois, S., Li, S., Martel, C., and Labrie, F. Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 14: 299-306, 1989.
19. Dauvois, S., Spinola, P. G., and Labrie, F. Additive inhibitory effects of bromocriptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat. Eur. J. Cancer Clin. Oncol., 25: 891-897, 1989.
20. Simard, J., Labrie, C., Bélanger, A., Gauthier, S., Singh, S. M., Mérand, Y., and Labrie, F. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro. Int. J. Cancer, 73: 104-112, 1997.
21. Murphy, G. P., Lawrence, W., Jr., and Lenhard, R. E., Jr. Basis for major current therapies for cancer. In: American Cancer Society Textbook of Clinical Oncology, pp. 102-110. Atlanta: American Cancer Society. 1995.
22. Sklar, G. N., Eddy, H. A., Jacobs, S. C., and Kyprianou, N. Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. J. Urol., 150: 1526-1532, 1993.